| ²é¿´: 3309 | »Ø¸´: 11 | |||||||
³ÕÃÎäìÏæÄ¾³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
×î½üNature/Science½ÒÃØÈý´óÀÏÒ©£¨ÖÐÒ©³£É½¡¢¶Ô°±»ùË®ÑîËá¡¢¶þ¼×Ë«ëÒ£©Ò©Àí×÷ÓûúÖÆ ÒÑÓÐ11È˲ÎÓë
|
|
×î½üNature/ScienceÂ½Ðø½ÒÃØÁËÈý¸ö¾µäÀÏÒ©µÄÒ©Àí»úÖÆ£¬ËüÃÇ·Ö±ðÊÇÖÐÒ©³£É½¡¢¶Ô°±»ùË®ÑîËá¡¢¶þ¼×Ë«ëÒ¡£ ³£É½¼î£¨febrifugine£©ÊÇÖÐÒ©³£É½£¨Dichroa febrifuga Lour.£©µÄ»îÐԳɷ֣¬ÓÃÓÚÖÎÁÆÅ±¼²ÒýÆðµÄ·¢ÈÈÒÑÓÐ2000ÄêÀúÊ·¡£³£É½Íª£¨halofuginone£©Êdz£É½¼îµÄ±´úÑÜÉúÎ¾ßÓÐÖÎÁư©Ö¢ºÍÏËά»¯¼²²¡µÄDZÁ¦¡£³£É½ÍªÍ¨¹ýÒÖÖÆ¸¬°±õ£tRNAºÏ³Éø£¨prolyl-transfer RNA synthetase, ProRS£©£¬×è¶Ïµ°°×ÖʵķÒëºÏ³É£¬É±ËÀ¸÷ÖÖϸ°û¡£ ProRSÊǰ±õ£tRNAºÏ³ÉøµÄÒ»ÖÖ£¬ÕâÀàø´ß»¯µÄ·´Ó¦ÊÇ£º °±»ùËá+ tRNA + ATP ¡ú °±õ£-tRNA + AMP + PPi Ðí¶à°±õ£tRNAºÏ³ÉøÒÖÖÆ¼Áͨ¹ýÄ£Äâ°±õ£-AMPµÄ½á¹¹£¬×è¶Ï°±»ùËáºÍATPµÄ½áºÏλµã£¬²úÉúÒÖÖÆ»îÐÔ¡£ÓÐȤµÄÊÇ£¬³£É½ÍªÒÖÖÆProRSÈ´ÐèÒªATPµÄ²ÎÓ룬ÕâÊÇÎªÊ²Ã´ÄØ£¿ Scripps Research InstituteµÄÑо¿ÈËÔ±£¨»ªÒᣩÄõ½ÁËProRS-ATP-HFµÄ¹²½á¾§£¨PDB code£º4HVC£©£¬ÏÔʾ³£É½ÍªµÄßßऻ·Ä£Ä⸬°±Ëá½á¹¹£¬µ«²»×èÖ¹ATPµÄ½áºÏ£¬Ïà·´»¹ÓëATPµÄÁ×Ëá»ùÍÅÐγÉÇâ¼ü¡£ Reference: Huihao Zhou, Litao Sun, Xiang-Lei Yang, Paul Schimmel. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase. Nature. doi:10.1038/nature11774. ¶Ô°±»ùË®ÑîËᣨpara-aminosalicylic acid, PAS£©ºÍ»Ç°·Ò©£¨sulfonamide£©¶¼ÊÇͨ¹ýÄ£Äâ¶þÇâÒ¶ËáºÏ³Éø£¨dihydropteroate synthase, DHPS£©µÄÌìÈ»µ×Îï¶Ô°±»ù±½¼×Ëᣨp-aminobenzoate, PABA£©£¬ÒÖÖÆDHPS»îÐÔ£¬×è¶ÏÒ¶ËáºÏ³É¶ø·¢»Ó×÷Óá£È»¶ø£¬PASËäȻֻÓÐÖеȵÄDHPSÒÖÖÆ»îÐÔ£¬µ«¶Ô½áºË·ÖÖ¦¸Ë¾ú£¨Mycobacterium tuberculosis£©ÓкܺõÄÒÖÖÆ×÷Ó㬶øÐí¶à¸ß»îÐÔµÄDHPSÒÖÖÆ¼ÁÈ´¶Ô½áºË·ÖÖ¦¸Ë¾úÎÞЧ£¬ÁíÍâ»Ç°·¼×¶ñßò£¨sulfamethoxazole, SMZ£©¡¢°±±½»Çõ£°·£¨sulfanilamide, SNL£©¡¢°±±½í¿£¨dapsone, APS£©Èý¸öÒ©µÄKiÖµ¶¼ÔÚ10-90nMÖ®¼ä£¬SMZ¶Ô½áºË·ÖÖ¦¸Ë¾úÓÐÖеȻîÐÔ£¬SNLºÍAPSÈ´ÍêÈ«ÎÞЧ£¬ÕâÊÇÎªÊ²Ã´ÄØ£¿ Weill Cornell Medical CollegeµÄÑо¿ÈËÔ±·¢ÏÖ£¬ÔÚ¶Ô½áºË·ÖÖ¦¸Ë¾ú¸øÓèPSAºó£¬Äܹ»¼ì²âµ½PABA¡¢serine¡¢homocysteine¡¢AICAR¡¢dUMPµÈ¶àÖÖ´úл²úÎïµÄÔö¼Ó£¬¶ø»Ç°·Ò©Ö»ÄÜÔö¼ÓPABAŨ¶È¡£ÁíÒ»·½Ã棬ËûÃÇ֤ʵPSAÊǽáºË·ÖÖ¦¸Ë¾úDHPS£¨FolP1£©µÄµ×ÎÄܹ»ºÏ³É¶þÇâÒ¶ËáµÄÀàËÆÎï¡£ÕâЩ֤¾Ý±íÃ÷£¬PSAµÄ¿¹¾ú»úÀíÓë»Ç°·Ò©²»Í¬£¬ËüÄܹ»ÏñPABAÒ»Ñù²ÎÓë´úл£¬²¢ÇÒÒÖÖÆDHPSÏÂÓÎÏà¹ØµÄø¡£ Reference: Chakraborty S, Gruber T, Barry CE 3rd, Boshoff HI, Rhee KY. Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis. Science. 2013, 339, 88-91. ¶þ¼×Ë«ëÒÊÇÁÙ´²×î³£ÓõĿڷþ½µÌÇÒ©Ö®Ò»£¬µ«ËüµÄ¾ßÌå×÷ÓûúÖÆÈ´Ò»Ö±ÊǸöÃÕ¡£10Äêǰ£¬ÓÐÈËÌá³ö¶þ¼×Ë«ëÒͨ¹ý¼¤»îAMPK¼¤Ã¸£¨AMP-activated protein kinase£©·¢»Ó×÷Ó㬵«ËæºóUniversity of PennsylvaniaµÄÑо¿ÈËԱͨ¹ýÒÅ´«Ñ§¹¦ÄÜȱʧʵÑ飨genetic loss-of-function experiments£©·´²µÁËÕâÒ»½âÊÍ£¬È±Ê§AMPK»òÉÏÓε°°×LKB1µÄСÊóÆä¸ÎÔàÈÔÈ»Äܹ»¶Ô¶þ¼×Ë«ëÒ×ö³ö·´Ó¦£¬±íÃ÷¸ÉÔ¤ÁËAMPKÒÔÍâµÄÐźš£×î½üUniversity of PennsylvaniaµÄÔ°àÈËÂíÔÚNatureÉÏ׫ÎÄÖØÐ½âÊͶþ¼×Ë«ëÒ½µÑªÌǵÄ×÷ÓûúÖÆ£¬ËûÃÇÖ¸³ö¶þ¼×Ë«ëÒÊÇͨ¹ýÒÖÖÆÒȸßѪÌÇËØÐźÅͨ·£¨glucagon signalling pathways£©¶ø·¢»Ó×÷Óõġ£ ÒȸßѪÌÇËØÓë¸Îϸ°ûĤÉϵÄÊÜÌ壨һÖÖGµ°°×żÁªÊÜÌ壩½áºÏºó£¬¼¤»îÏÙÜÕËá»·»¯Ã¸£¨adenylyl cyclase£©£¬²úÉúµÚ¶þÐÅʹcAMP£¬¼¤»îPKA²¢Á×ËữÏÂÓε°°×£¬Ôö¼Ó¸ÎÌÇÊä³ö¡£Ñо¿·¢ÏÖ£¬±½ÒÒË«ëÒÄÜÒÖÖÆÒȸßѪÌÇËØÓÕµ¼µÄcAMPÉú³É£¬²¢ÇÒÕâÖÖÒÖÖÆ×÷ÓÃËæ±½ÒÒË«ëҵļÁÁ¿Ôö¼Ó¶øÔö¼Ó£¨dose-dependent£©£¬IC50´óÔ¼ÔÚ150¦ÌM¡£ÔÚ´óÊóÖУ¬¸øÓè50 mg/kgµÄ¼ÁÁ¿£¬¾Í×ãÒÔʹ¸ÎÔàÖÐÒ©ÎïŨ¶È´ïµ½250¦ÌMÒÔÉÏ£¬Ëæºó֤ʵ¶þ¼×Ë«ëÒÒ²ÓÐÀàËÆµÄ×÷Ó᣶þ¼×Ë«ëÒ½µµÍcAMPµÄŨ¶ÈµÄͬʱÔö¼ÓAMPµÄŨ¶È£¬¶øº¬ÓÐÏÙàÑßʽṹµÄ·Ö×Óͨ³£ÄÜÕ¼¾ÝÏÙÜÕËá»·»¯Ã¸µÄP-site£¬ÒÖÖÆÆä»îÐÔ¡£ Reference: Russell A. Miller, Qingwei Chu, Jianxin Xie, Marc Foretz, Benoit Viollet, Morris J. Birnbaum. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature. 2013, doi:10.1038/nature11808 |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ÎÄÏ×ÍÆ¼ö | ¿ÆÑÐÙYÁÏ | ÓÐÓÃÎÄÕ | »Ç°·ºÏ³É |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
¹ØÓÚSCIÔÓÖ¾·¢±í¹ÒÃû
ÒѾÓÐ32È˻ظ´
2026Éê²©ÍÆ¼ö
ÒѾÓÐ1È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ286È˻ظ´
һƪÀ©É¢Ä£Ð͵ÄNature Machine IntelligenceÂÛÎĺÍElsevierÉϵÄÉî¶ÈѧϰҩÎïÊé¼®
ÒѾÓÐ1È˻ظ´
ÖйúÒ©¿Æ´óѧ2026Èëѧ²©Ê¿£¬Ò©ÎïºÏ³ÉºÍÉè¼Æ¾Ñ飬·ÅÉ仯ѧ¼°·ÅÉäҽѧÑо¿
ÒѾÓÐ25È˻ظ´
ʹÓÃMolAICal½øÐжàëÄÐéÄâɸѡ½Ì³Ì-ͬÑùÊÊÓÃÓÚµ°°×ÖʺͺËËáµÄÐéÄâɸѡ
ÒѾÓÐ1È˻ظ´
ʹÓÃMolAICal¼ÆËãÒ©Îﻯѧ¹ýÂËÆ÷MCFs¼°MCE-18ÃèÊö·û
ÒѾÓÐ0È˻ظ´
ʹÓÃMolAICal·¢ÏÖµ°°×ÊÜÌåDZÔڵĻîÐÔ¿Ú´ü¼°Î»µã
ÒѾÓÐ0È˻ظ´
»ªÀíҩѧѧ˶Çóµ÷¼Á£¬×Ü·Ö324
ÒѾÓÐ0È˻ظ´
°ÄÃÅÀí¹¤´óѧÈ˹¤ÖÇÄÜÒ©Îï·¢ÏÖÖÐÐÄÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú£¨ÉêÇë-¿¼ºËÖÆ£©
ÒѾÓÐ9È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
xufund
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 18237.5
- É¢½ð: 20
- ºì»¨: 5
- Ìû×Ó: 6734
- ÔÚÏß: 811.7Сʱ
- ³æºÅ: 311488
- ×¢²á: 2006-12-30
- רҵ: ºÏ³ÉÒ©Îﻯѧ
2Â¥2013-01-08 21:56:19
garysun
½ð³æ (ÕýʽдÊÖ)
¹¤³Ìʦ
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ½ð±Ò: 1381.5
- ºì»¨: 1
- Ìû×Ó: 330
- ÔÚÏß: 210.3Сʱ
- ³æºÅ: 1592624
- ×¢²á: 2012-01-31
- ÐÔ±ð: GG
- רҵ: ·ð½Ì
3Â¥2013-01-09 14:06:27
myy1787
Ìú³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 19684
- ºì»¨: 20
- Ìû×Ó: 1238
- ÔÚÏß: 4510.5Сʱ
- ³æºÅ: 577405
- ×¢²á: 2008-06-22
4Â¥2013-01-09 22:17:23
dayongpeng80
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 41 (СѧÉú)
- ½ð±Ò: 3166.8
- ºì»¨: 3
- Ìû×Ó: 966
- ÔÚÏß: 325.1Сʱ
- ³æºÅ: 145110
- ×¢²á: 2005-12-24
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É

5Â¥2013-01-09 22:52:54
![]() ![]() |
6Â¥2013-01-10 10:58:50
pal2004
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 54 (³õÖÐÉú)
- ½ð±Ò: 3936.2
- ºì»¨: 4
- Ìû×Ó: 808
- ÔÚÏß: 179.7Сʱ
- ³æºÅ: 192849
- ×¢²á: 2006-02-21
- רҵ: Ò©Îﻯѧ
7Â¥2013-01-10 11:27:23
guanghua02
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 26 (СѧÉú)
- ½ð±Ò: 3364.4
- É¢½ð: 6
- ºì»¨: 5
- Ìû×Ó: 457
- ÔÚÏß: 436.3Сʱ
- ³æºÅ: 706234
- ×¢²á: 2009-02-22
- רҵ: ÓлúºÏ³É
8Â¥2013-01-10 11:38:35
![]() |
9Â¥2013-01-10 12:27:28
jonathonswq
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 30 (СѧÉú)
- ½ð±Ò: 3893.7
- É¢½ð: 52
- ºì»¨: 3
- Ìû×Ó: 441
- ÔÚÏß: 91.7Сʱ
- ³æºÅ: 1044494
- ×¢²á: 2010-06-20
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ

10Â¥2013-01-11 12:47:35













»Ø¸´´ËÂ¥
myy1787

